Researchers Find 2 Neural Pathways That Play Role In Developing Phobias
Their findings, published in the journal Neuron may pave the way for more targeted treatment of chronic fear and anxiety disorders. Such conditions affect at least 25 million Americans and include panic attacks, social phobias, obsessive-compulsive behavior and post-traumatic stress disorder.
n the brain imaging study, researchers from UC Berkeley and Cambridge University discovered two distinct neural pathways that play a role in whether we develop and overcome fears. The first involves an overactive amygdala, which is home to the brain's primal fight-or-flight reflex and plays a role in developing specific phobias.
The second involves activity in the ventral prefrontal cortex, a neural region that helps us to overcome our fears and worries. Some participants were able to mobilize their ventral prefrontal cortex to reduce their fear responses even while negative events were still occurring, the study found.
"This finding is important because it suggests some people may be able to use this ventral frontal part of the brain to regulate their fear responses - even in situations where stressful or dangerous events are ongoing," said UC Berkeley psychologist Sonia Bishop, lead author of the paper.
"If we can train those individuals who are not naturally good at this to be able to do this, we may be able to help chronically anxious individuals as well as those who live in situations where they are exposed to dangerous or stressful situations over a long time frame," Bishop added.
Bishop and her team used functional Magnetic Resonance Imaging (fMRI) to examine the brains of 23 healthy adults. As their brains were scanned, participants viewed various scenarios in which a virtual figure was seen in a computerized room. In one room, the figure would place his hands over his ears before a loud scream was sounded. But in another room, the gesture did not predict when the scream would occur. This placed volunteers in a sustained state of anticipation.
Participants who showed overactivity in the amygdala developed much stronger fear responses to gestures that predicted screams. A second entirely separate risk factor turned out to be failure to activate the ventral prefrontal cortex. Researchers found that participants who were able to activate this region were much more capable of decreasing their fear responses, even before the screams stopped.
The discovery that there is not one, but two routes in the brain circuitry that lead to heightened fear or anxiety is a key finding, the researchers said, and it offers hope for new targeted treatment approaches.
"Some individuals with anxiety disorders are helped more by cognitive therapies, while others are helped more by drug treatments," Bishop said. "If we know which of these neural vulnerabilities a patient has, we may be able to predict what treatment is most likely to be of help."
In addition to Bishop, coauthors of the study are Anwar O. Nunez Elizalde at UC Berkeley; Iole Indovina of the Neuroimaging Laboratory of the Santa Lucia Foundation in Rome, Italy; Trevor Robbins at Cambridge University in the United Kingdom; and Barney Dunn at the MRC Cognition and Brain Sciences Unit in Cambridge, U.K.
University of California - Berkeley
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Anwar, Yasmin. "Researchers Find 2 Neural Pathways That Play Role In Developing Phobias." Medical News Today. MediLexicon, Intl., 14 Feb. 2011. Web.
12 Feb. 2016. <http://www.medicalnewstoday.com/releases/216305.php>
Anwar, Y. (2011, February 14). "Researchers Find 2 Neural Pathways That Play Role In Developing Phobias." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.